Protopic is a popular eczema treating cream that allegedly causes cancer. In March 2005, the FDA issued a warning about the use of Protopic as a potential cancer-causing cream. Based on various tests done on animals, and a few cases where patients have reported discomfort with this medicine and other similar drugs, the FDA has stated that here is an uncertain risk to the health of the people who use this topical medicine. Since these results are still on the preliminary phase, there is still the need for further data analysis. Tests on humans may take ten or more years to be absolutely certain of the cancer causing effects of this medicine. Therefore, the FDA advices patients to use this cream when there is no other alternative left; when other treatments have failed to get rid of eczema, and only for limited periods of time. It is especially not recommended for people who have a weak immune system, since Protopic has been labeled as an immunosuppressant, which makes the person more vulnerable to any disease.
Despite the reports received by the FDA of children and adults claiming to have lymphoma or skin cancer, the maker, Fujisawa Pharmaceuticals, has not found a direct link between Protopic and disease. However, both have agreed to continue running some tests and in the mean time, be protected from any liabilities with the FDA warning.
The most common cancers reported include Skin Cancer, T-Cell Lymphoma, Basal Cell Carcinoma (BCC), Squamous Cell Carcinoma (SCC), Hodgkin's Lymphoma (HL), Non-Hodgkin's Lymphoma. Basal Cell Carcinoma is the most common skin cancer. Its primary symptoms include an open sore that does not heal, a patch of red skin, shiny mole-like bump, pink growth with a raised outer edge, scar-like patch like a scar tissue. If you experience any of these symptoms, and have been using Protopic, it is very important to consult a doctor to get these symptoms checked. If you feel like you have been a victim of this medicine, you are able to take legal action and may be entitled to monetary compensation to cover the medical costs for treating the cancer.